BTK Inhibitors Impair Platelet-Mediated Antifungal Activity

In recent years, the introduction of new drugs targeting Bruton’s tyrosine kinase (BTK) has allowed dramatic improvement in the prognosis of patients with chronic lymphocytic leukemia (CLL) and other B-cell neoplasms. Although these small molecules were initially considered less immunosuppressive th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasillo, Vincenzo, Lagreca, Ivana, Vallerini, Daniela, Barozzi, Patrizia, Riva, Giovanni, Maccaferri, Monica, Paolini, Ambra, Forghieri, Fabio, Fiorcari, Stefania, Maffei, Rossana, Martinelli, Silvia, Atene, Claudio Giacinto, Castelli, Ilaria, Marasca, Roberto, Potenza, Leonardo, Comoli, Patrizia, Manfredini, Rossella, Tagliafico, Enrico, Trenti, Tommaso, Luppi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947638/
https://www.ncbi.nlm.nih.gov/pubmed/35326454
http://dx.doi.org/10.3390/cells11061003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947638/
https://www.ncbi.nlm.nih.gov/pubmed/35326454
http://dx.doi.org/10.3390/cells11061003

Ejemplares similares